SHP099 hydrochloride
CAS No. 1801747-11-4
SHP099 hydrochloride( —— )
Catalog No. M17381 CAS No. 1801747-11-4
SHP099 is a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 82 | In Stock |
|
10MG | 151 | In Stock |
|
50MG | 510 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSHP099 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionSHP099 is a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.
-
DescriptionSHP099 is a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
RecptorSHP-2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1801747-11-4
-
Formula Weight388.72
-
Molecular FormulaC16H20Cl3N5
-
Purity>98% (HPLC)
-
SolubilityMethanol : 15 mg/mL 38.59 mM; DMSO : 4.1 mg/mL 10.55 mM; H2O : ≥ 2.5 mg/mL 6.43 mM
-
SMILESNc1nc(N2CCC(C)(N)CC2)cnc1c1cccc(Cl)c1Cl.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chen YN, et al. Nature. 2016 Jul 7;535(7610):148-52.
molnova catalog
related products
-
Metoclopramide hydro...
Metoclopramide hydrochloride is a selective dopamine D2 receptor antagonist, used for the treatment of nausea and vomiting.
-
CART (62-76) (rat, h...
Cocaine- and amphetamine-regulated transcript (CART) peptide fragment that inhibits food intake. Attenuates NPY-induced feeding and decreases food intake in food-restricted goldfish, and induces anxiogenic-like effects in elevated plus-maze test in rats. Modulates the activity of striatal noradrenergic, and corticostrial and hypothalamic serotoninergic systems, with no major effect on dopaminergic pathways in rat brain.
-
RS 127445
RS 127445 is a selective high affinity orally bioavailable 5-HT2B receptor antagonist(pKi : 9.5).